Home/Alixia/Ken Nakamura, MD, Ph.D.
KN

Ken Nakamura, MD, Ph.D.

Advisor

Alixia

Alixia Pipeline

DrugIndicationPhase
Tumor Ecosystem DisruptorsSolid TumorsPreclinical